2021 PrEP Clinical Practice Guideline – Clinical Providers’ Supplement

Updated Clinical Providers’ Supplement accompanying the 2021 PrEP Clinical Practice Guideline.

Updates for 2021 include:

  • Checklist updated to include Descovy, 2-1-1 Truvada for MSM, and cabotegravir
  • Added PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) recommendation for HIV prevention in adults 
  • Added information about Descovy and cabotegravir to Patient Information Sheets
CDC logo

2021 PrEP Clinical Practice Guideline

Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.

Updates for 2021 include:

  • A recommendation to inform all sexually active adults and adolescents about PrEP
  • PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.

Also view the updated PrEP Providers Supplement for 2021.

Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.

Updates for 2021 include:

  • A recommendation to inform all sexually active adults and adolescents about PrEP
  • PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.

Also view the updated PrEP Providers Supplement for 2021.

California STI Treatment Guidelines Table for Adults and Adolescents—2021

These guidelines reflect the 2021 CDC STI Treatment Guidelines for adults and adolescents who are HIV negative as well as those with HIV.

View the online version of the guidelines

CDC logo

Perinatal HIV and Congenital Syphilis—Dear Colleague Letter from CDPH

November 16, 2021: CDPH is asking for assistance in responding to concerning increases in congenital syphilis and perinatal HIV in California. Perinatal HIV transmission and congenital syphilis can be prevented with timely testing and treatment. A common risk factor, however, is receiving late or no prenatal care.

CDPH requests your assistance to implement the following policies and best practices to Screen, Treat and Prevent, and Prepare for perinatal transmissions

California Department of Public Health Logo

STI Clinical Update Webinar: San Francisco Department of Public Health, San Francisco City Clinic

November 4, 2021

The San Francisco Department of Public Health continues to see concerning rises in sexually transmitted infections (STIs).

This half-day, virtual event provides important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, important recommendations to prevent congenital syphilis, updates from the 2021 CDC STI Treatment Guidelines, and a lively case panel.

Learning Objectives

  1. Summarize current STI trends in San Francisco
  2. Identify and screen those most at risk for syphilis in San Francisco
  3. Describe updated treatment recommendations for chlamydia, gonorrhea, Mycoplasma genitalium, NGU, and trichomonas

PrEP Provider Pocket Card

Clinical PrEP essentials and key messages available in an easily accessible pocket card. From SF CBA and the San Francisco Health Network. 

person holding blue pills

STD Clinical Update Webinar: Congenital Syphilis Prevention Update for California Family Planning and Primary Care Providers

September 28, 2021

Presented by Drs. Eric Tang and Sara Kennedy

The California Department of Public Health (CDPH) continues to see dramatic statewide increases in cases of congenital syphilis (CS), a severe yet preventable condition when syphilis is passed from mother to fetus. This webinar, presented by the California Prevention Training Center, features Dr. Eric Tang, public health medical officer at CDPH, who will provide a clinical overview of CS prevention and discuss the new Expanded Syphilis Screening Recommendations from CDPH as it relates to family planning and primary care providers.  

After his presentation, Dr. Sara Kennedy, Chief Medical Officer of Planned Parenthood Northern California, will present her organization’s experience implementing expanded syphilis screening in their clinics to detect and treat syphilis cases to ultimately prevent CS cases in California. 

Learning Objectives

  1. Understand the epidemiology and recognize the risk factors for syphilis and congenital syphilis in California
  2. Screen for syphilis based on the Expanded Syphilis Screening Recommendations from the California Department of Public Health
  3. Appropriately diagnose and manage syphilis cases in your practice

2021 CDC STI Treatment Guidelines Webinar

2021 CDC STI Treatment Guidelines Webinar presented by National Network of STD Prevention Training Center (NNPTC) faculty Dr. Ina Park, Dr. Rosalyn Plotzker, and Dr. Christine Johnston.

STD Expert Hour – Transgender Sexual Health: What You Should Know

August 26, 2021

This webinar is presented by Gayge Maggio, FNP-BC, AAHIVS and will focus on the sexual health needs of transgender and gender non-conforming people.

There will be a focus on learning to approach sexual health in a culturally sensitive, non-judgmental manner.

Unique PrEP and PEP considerations in TGNC populations will be covered, as will contraceptive options for female assigned at birth TGNC patients.

Learning Objectives:

  1. Discuss and perform a culturally sensitive sexual health inventory with transgender patients
  2. Discuss considerations with PrEP and PEP in transgender populations and provide appropriate PrEP options
  3. Discuss options for contraception in assigned female at birth transgender and gender non-conforming patients

STD Clinical Update Webinar – Congenital Syphilis Update for CA Jail Providers

July 27, 2021

This webinar features Dr. Rosalyn Plotzker and Ms. Laura Kovaleski, co-authors of the CDPH Expanded Syphilis Screening Recommendations for the Prevention of Congenital Syphilis, who will provide a clinical overview of CS prevention and discuss the recommendation to screen women in correctional facilities for syphilis. Finally, Dr. Kristin Walsh, physician with Santa Clara County’s Adult Custody Health Services and HIV specialist at Santa Clara Valley Medical Center’s PACE clinic, will present the county’s experience implementing such screening practices.

Learning Objectives:

  1. Describe California’s CS epidemiology and incorporate data into screening
  2. Discuss the importance of prenatal syphilis diagnosis, evaluation, and management
  3. Explain and apply CDPH recommendation to screen women for syphilis in adult correctional facilities